Skip to main content
Industry News
FDA extends comment period for 510(k) revamp proposal

The FDA has extended for 30 days the comment period for its proposed 510(k) pathway changes, setting the new deadline at May 22. The proposal seeks to discourage the use of older predicates by releasing a list of medical devices that were based on predicates over a decade old.

Full Story: